Clinical Trial Update: Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 multicenter single ascending-dose trial of PE0139 in adults with Type 2 Diabetes Mellitus completed, assessing safety, tolerability, pharmacokinetics an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PE0139 (PE0139)

Snippet

Sponsor: PhaseBio Pharmaceuticals Inc. | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 1 | Status: COMPLETED